<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013594</url>
  </required_header>
  <id_info>
    <org_study_id>4-2019-0428</org_study_id>
    <nct_id>NCT04013594</nct_id>
  </id_info>
  <brief_title>Effect of Preoperative Oral Carbohydrates on the Glycemic Variability of Diabetic Patients</brief_title>
  <official_title>Effect of Preoperative Oral Carbohydrates on the Glycemic Variability of Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative carbohydrate drink intake attenuate insulin resistance. However, carbohydrate
      loading may compromise blood glucose control in patients with diabetes. There is some
      evidence that oral carbohydrate loading may be safe in patients with type 2 diabetes.
      Therefore, the investigators aim to evaluate whether preoperative carbohydrate intake affects
      insulin resistance and glycemic variability in patients with diabetes. Fifty patients
      scheduled for total knee arthroplasty will be divided into carbohydrate (n=25) and control
      (n=25) groups. Randomly selected patients of the carbohydrate group are given 400ml of 12.8
      g/100 ml carbohydrate beverage 2-3 hours before their scheduled operation. In contrast,
      patients in the control group are fasted from water 2 hours before surgery according to
      standard protocol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>- Coefficient of glucose variability =SD/mean x 100 (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>- J index=0.001 x (MBG +SD)2 mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>immediately after anesthesia</time_frame>
    <description>- Coefficient of glucose variability =SD/mean x 100 (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>immediately after anesthesia</time_frame>
    <description>- J index=0.001 x (MBG +SD)2 mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>operation end</time_frame>
    <description>- Coefficient of glucose variability =SD/mean x 100 (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>operation end</time_frame>
    <description>- J index=0.001 x (MBG +SD)2 mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>- Coefficient of glucose variability =SD/mean x 100 (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic variability</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>- J index=0.001 x (MBG +SD)2 mg/dL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>Insulin resistance index = fasting glucose x fasting insulin/22.5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>serum laboratory test: glucagon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>serum laboratory test: GLP-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>serum laboratory test: C-peptide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>serum laboratory test: free fatty acid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gastric volume</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>gastric volume measured by ultrasonography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hand grip strength</measure>
    <time_frame>Before anesthesia</time_frame>
    <description>hand grip strength measured by electronic hand dynamometer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>carbohydrate group(CHO group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>carbohydrate group</intervention_name>
    <description>Randomly selected patients of the carbohydrate group are given oral carbohydrate (400ml) 2-3 hours before surgery.</description>
    <arm_group_label>carbohydrate group(CHO group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Patients undergoing total knee arthroplasty

        Exclusion Criteria:

          -  1. Patients with contraindications to spinal anesthesia (local infection, clotting
             disorders, anatomical abnormalities, sepsis, etc.)

          -  2. Patients with gastroesophageal reflux disease, gastric emptying disorders,
             inflammatory bowel disease, or previous treatment for intra-abdominal cancer

          -  3. Patients with chronic renal disease or severe cardiovascular disease

          -  4. HbA1c &gt;69 mmol/mol or BMI &gt;30 kg/m2

          -  5. A duration of ≥5 hours between consumption of CHO and initiation of surgery.

          -  6. The subject is a foreigner or illiterate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yong Seon Choi, MD., Ph.D</last_name>
    <phone>82-2-2228-2412</phone>
    <email>YSCHOI@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Seon Choi, MD, Ph.D</last_name>
      <phone>82-2-2228-2412</phone>
      <email>yschoi@yush.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab. 2001 Apr;280(4):E576-83.</citation>
    <PMID>11254464</PMID>
  </reference>
  <reference>
    <citation>Gustafsson UO, Nygren J, Thorell A, Soop M, Hellström PM, Ljungqvist O, Hagström-Toft E. Pre-operative carbohydrate loading may be used in type 2 diabetes patients. Acta Anaesthesiol Scand. 2008 Aug;52(7):946-51. doi: 10.1111/j.1399-6576.2008.01599.x. Epub 2008 Mar 7.</citation>
    <PMID>18331374</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

